SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-15-000378
Filing Date
2015-01-16
Accepted
2015-01-16 16:17:51
Documents
1
Period of Report
2015-01-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3010615beck_relmada.html 3  
1 OWNERSHIP DOCUMENT f3010615beck_relmada.xml 3 3080
  Complete submission text file 0001213900-15-000378.txt   4541
Mailing Address C/O IBIO, INC. 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address
BECK DOUGLAS (Reporting) CIK: 0001267110 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55347 | Film No.: 15532847

Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations